{"id":"W4401897141","doi":"10.1016/s2152-2650(24)01563-5","title":"IBCL-335 Mosunetuzumab Monotherapy Continues to Demonstrate Durable Responses in Patients With Relapsed and/or Refractory Follicular Lymphoma After ≥2 Prior Therapies: 3-Year Follow-Up From a Pivotal Phase II Study","year":2024,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre; Jewish General Hospital; Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Medicine; Follicular lymphoma; Refractory (planetary science); Internal medicine; Follicular phase; Oncology; Phases of clinical research; Lymphoma; Clinical trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001728498,0.0007444169,0.001717383,0.0003119198,0.0004445981,0.001214565,0.0004801471,0.0007149759,0.002179291],"category_scores_gemma":[0.0007794548,0.0002450763,0.00118754,0.000356642,0.0004474376,0.000805484,0.0002421342,0.002024332,0.0008715048],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008512837,"about_ca_system_score_gemma":0.0007946081,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001023932,"about_ca_topic_score_gemma":0.004194202,"domain_scores_codex":[0.9995838,0.0001301418,0.00002557722,0.00005552506,0.00005504375,0.000149853],"domain_scores_gemma":[0.9993925,0.0001186657,0.0001380849,0.00006197939,0.00005643729,0.0002322372],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.2436395,0.01399077,0.04232669,0.00130246,0.0047309,0.0005896637,0.0004870545,0.002935388,0.09407571,0.0004957366,0.01797283,0.5774533],"study_design_scores_gemma":[0.2508637,0.3554184,0.3133393,0.00040918,0.004946548,0.002336267,0.0004325975,0.004244064,0.02241952,0.0009238785,0.04452398,0.0001426552],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9832123,0.01049437,0.0004347482,0.0008927579,0.0001385783,0.0003542936,0.001140322,0.0001324087,0.003200251],"genre_scores_gemma":[0.9915069,0.002684811,0.0005208227,0.001138904,0.0001206671,0.0001823543,0.002265368,0.00002848467,0.001551813],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002179291,"threshold_uncertainty_score":0.009141326,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01894481522085363,"score_gpt":0.312418980438829,"score_spread":0.2934741652179754,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}